国家医保局章轲：目前已有逾百个品种药品申请纳入商保创新药目录

Core Insights - The National Healthcare Security Administration (NHSA) has revealed that over 100 drug varieties have applied for inclusion in the innovative drug directory through single and dual directory applications [1] Group 1 - The NHSA is committed to following the prescribed procedures for the subsequent work related to the inclusion of these drugs [1]